Professor25/iStock by way of Getty Pictures
- DBV Applied sciences (NASDAQ:DBVT) inventory shot up 29% in post-market buying and selling Wednesday after the corporate stated it has aligned with the FDA on an accelerated approval pathway for its peanut allergy patch Viaskin for youngsters aged one to a few years.
- The
